Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

ivosidenib MeSH Supplementary Concept Data 2025


MeSH Supplementary
ivosidenib
Unique ID
C000627630
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000627630
Entry Term(s)
AG-120
AG120
N-((1S)-1-(2-chlorophenyl)-2-((3,3-difluorocyclobutyl)amino)-2-oxoethyl)-1-(4-cyano-2-pyridinyl)-N-(5-fluoro-3-pyridinyl)-5-oxo-L-prolinamide
Tibsovo
Pharm Action
Antineoplastic Agents
Enzyme Inhibitors
Registry Numbers
Q2PCN8MAM6
Heading Mapped to
Glycine / analogs & derivatives
*Pyridines
Frequency
83
Note
an inhibitor of isocitrate dehydrogenase 1 (IDH1) for treatment of acute myeloid leukemia (AML)
Source
N Engl J Med. 2018 Jun 21;378(25):2386-2398.
Date of Entry
2018/07/16
Revision Date
2022/07/28
ivosidenib Preferred
AG-120 Narrower
Tibsovo Related
page delivered in 0.005s